Possessing recognized the palmitoylation motif of APLNR, we developed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web page together with morphine, can inhibit the development of NCP, together with pain incidence, microglial activation, and inflammatory component https://conolidine35642.mdkblog.com/32492791/block-pain-receptors-with-proleviate-secrets